Back to Search
Start Over
Molecular Staging of Sentinel Lymph Nodes Identifies Melanoma Patients at Increased Risk of Nodal Recurrence
- Source :
- Journal of the American College of Surgeons. 222(4)
- Publication Year :
- 2015
-
Abstract
- Background Molecular staging of sentinel lymph nodes (SLNs) may identify patients who are node-negative by standard microscopic staging but are at increased risk for regional nodal recurrence; such patients may benefit from completion lymph node dissection (CLND). Study Design In a multicenter, randomized clinical trial, patients with tumor-negative SLNs by standard pathology (hematoxylin and eosin [H and E] serial sections and immunohistochemistry [IHC]) underwent reverse transcriptase polymerase chain reaction (PCR) analysis of SLNs for melanoma-specific mRNA. Microscopically negative/PCR+ patients were randomized to observation, CLND, or CLND with high-dose interferon (HDI). For this post-hoc analysis, clinicopathologic features and survival outcomes, including overall survival (OS) and disease-free survival (DFS), were compared between PCR+ patients who underwent CLND vs observation. Microscopic and molecular node-negative (PCR-) patients were included for comparison. Results A total of 556 patients were PCR+: 180 underwent observation, and 376 underwent CLND. An additional 908 PCR- patients were observed. Median follow-up was 72 months. Disease-free survival (DFS) was significantly better for PCR+ patients who underwent CLND compared with observation (p = 0.0218). No statistically significant differences in OS or distant disease-free survival (DDFS) were seen. Regional lymph node recurrence-free survival (LNRFS) was improved in PCR+ patients with CLND compared to observation (p = 0.0065). The PCR+ patients in the observation group had the worst DFS; those with CLND had similar DFS to that in the PCR- group (p = 0.9044). Conclusions Patients with microscopically negative/PCR+ SLN have an increased risk of nodal recurrence that was mitigated by CLND. Although CLND did not affect OS, these data suggest that molecular detection of melanoma-specific mRNA in the SLN predicts a greater risk of nodal recurrence and deserves further study.
- Subjects :
- 0301 basic medicine
Adult
Male
medicine.medical_specialty
Skin Neoplasms
Sentinel lymph node
H&E stain
Antineoplastic Agents
Gastroenterology
Sensitivity and Specificity
Disease-Free Survival
03 medical and health sciences
0302 clinical medicine
MART-1 Antigen
Antigens, Neoplasm
Internal medicine
medicine
Humans
RNA, Messenger
Watchful Waiting
Lymph node
Melanoma
Aged
Neoplasm Staging
business.industry
Monophenol Monooxygenase
Reverse Transcriptase Polymerase Chain Reaction
Sentinel Lymph Node Biopsy
Hazard ratio
Middle Aged
medicine.disease
Surgery
Neoplasm Proteins
Dissection
030104 developmental biology
medicine.anatomical_structure
Molecular Diagnostic Techniques
030220 oncology & carcinogenesis
Immunohistochemistry
Female
Lymph
Interferons
Neoplasm Recurrence, Local
business
gp100 Melanoma Antigen
Subjects
Details
- ISSN :
- 18791190
- Volume :
- 222
- Issue :
- 4
- Database :
- OpenAIRE
- Journal :
- Journal of the American College of Surgeons
- Accession number :
- edsair.doi.dedup.....7457747562a62ed7c76d5ee796a2644c